DhRS
Holy hell, this is so good. The comments highlighted some stuff I had overlooked and were very relevant too, unlike the generic ones one would get from ChatGPT/Claude. Surely, there is a human in the loop?
I've been working on a new tool, Refine, to make scholars more productive. If you're interested in being among the very first to try the beta, please read on. Refine leverages the best current AI models to draw your attention to potential errors and clarity issues in research paper drafts. 1/
Sure, some would ultimately lead to new meds, optimization of existing meds. But most will "fail" too. Knowing something does not work is equally cool too. It's still expanding human knowledge. As someone who finds fulfillment in bittersweet process of research, it's a lose-lose situation to be in 2
A question on ps matching for #StatsSky, #EpiSky folks. If I have a treatment (X) group where X is given at an outpatient visit. I would like a control group who had the similar visit but without X. But a patient can have multiple visits, hence multiple index time for being a control. In the past, 1
You are up to date.